Canonically, PHGDH has been considered the rate-limiting step of the SSP, and apart from ER/PR+ breast cancer, most instances of SSP suppression in other cell lines involved PHGDH downregulation (12,23–25). The gene discussed is PHGDH; the disease is breast cancer.